Skye Bioscience Treats First Patient in Nimacimab Dose Study
In prior Phase 2a work, nimacimab combined with semaglutide delivered 22.3% mean weight loss at 52 weeks with no...
eClinical Tech News
Priovant Launches New Brepocitinib Trial for LPP Hope
Priovant has begun enrolling a seamless Phase 2b/3 trial of brepocitinib in lichen planopilaris (LPP), with first patients dosed...
Promising New Eye Pain Trial Begins With First Patient Dosed
Pelthos Therapeutics has dosed the first patient in a Phase 1b/2a study of CT2000, a topical NaV1.7 inhibitor eye...
Tarsus Doses First Patient in Lyme Disease Prevention Trial
In earlier proof-of-concept work, a single oral dose of TP-05 (lotilaner) produced more than 90% tick mortality within 24...
Pheast Therapeutics Advances New Cancer Drug to Phase 1b Trial
Pheast Therapeutics has dosed the first patient in the Phase 1b combination portion of its ongoing Phase 1 study...
Actinogen Commences Xanamia Alzheimer’s Open-Label Trial
No efficacy data yet. Actinogen has initiated the open-label extension of its XanaMIA pivotal program in Alzheimer’s disease, dosing...
ZUSDURI Delivers 72.2% Durable Response in enVision Trial
ZUSDURI delivered a 79.6% complete response at three months in the pivotal Phase 3 ENVISION study, with a Kaplan-Meier–estimated...
Tonix Starts Phase 1 Trial for New Migraine Pain Treatment
Tonix Pharmaceuticals has dosed the first participant in an investigator-initiated Phase 1 study of TNX-1900, an intranasal, magnesium-potentiated oxytocin...
GlucoTrack Targets Early Q2 For US FDA Clinical Trial Filing
Glucotrack’s first-in-human study of its fully implantable continuous blood glucose monitor reported a Mean Absolute Relative Difference of 7.7%...
First Patient Dosed in RAD 402 Advanced Prostate Cancer Trial
Radiopharm Theranostics has dosed the first patient in its first-in-human Phase 1 trial of RAD 402 in advanced prostate...